| Cardiac Arrest and Resuscitation | Lifetime | 41 | BE 3 | 99.75 |
| Long-Term Effects of COVID-19 | Lifetime | 47 | BE 1 | 99.25 |
| Traumatic Brain Injury and Neurovascular Disturbances | Lifetime | 70 | BE 4 | 99.73 |
| Sepsis Diagnosis and Treatment | Lifetime | 55 | BE 4 | 99.67 |
| Antibiotics Pharmacokinetics and Efficacy | Lifetime | 69 | BE 3 | 99.50 |
| COVID-19 Clinical Research Studies | Lifetime | 181 | BE 2 | 99.07 |
| Hemodynamic Monitoring and Therapy | Lifetime | 83 | BE 4 | 99.30 |
| Mechanical Circulatory Support Devices | Lifetime | 112 | BE 2 | 99.31 |
| Thermal Regulation in Medicine | Lifetime | 34 | BE 3 | 99.05 |
| Intensive Care Unit Cognitive Disorders | Lifetime | 113 | BE 5 | 99.16 |
| Antibiotic Use and Resistance | Lifetime | 208 | BE 7 | 98.53 |
| Respiratory Support and Mechanisms | Lifetime | 730 | BE 14 | 98.18 |
| Cerebrospinal fluid and hydrocephalus | Lifetime | 670 | BE 4 | 95.60 |
| Neurosurgical Procedures and Complications | Lifetime | 542 | BE 4 | 95.55 |
| Traumatic Brain Injury Research | Lifetime | 719 | BE 10 | 95.25 |
| Acute Kidney Injury Research | Lifetime | 579 | BE 15 | 94.76 |
| Blood transfusion and management | Lifetime | 593 | BE 5 | 92.90 |
| Renal function and acid-base balance | Lifetime | 952 | BE 19 | 92.69 |
| Traumatic Brain Injury and Neurovascular Disturbances | 2021-2025 | 2 | BE 1 | 99.91 |
| Cardiac Arrest and Resuscitation | 2021-2025 | 5 | BE 1 | 99.90 |
| Thermal Regulation in Medicine | 2021-2025 | 1 | BE 1 | 99.49 |
| Sepsis Diagnosis and Treatment | 2021-2025 | 32 | BE 3 | 99.31 |
| Mechanical Circulatory Support Devices | 2021-2025 | 38 | BE 1 | 99.18 |
| Long-Term Effects of COVID-19 | 2021-2025 | 106 | BE 1 | 98.64 |
| Neurosurgical Procedures and Complications | 2021-2025 | 16 | BE 1 | 98.47 |
| Cerebrospinal fluid and hydrocephalus | 2021-2025 | 29 | BE 1 | 97.25 |
| Intensive Care Unit Cognitive Disorders | 2021-2025 | 68 | BE 2 | 98.47 |
| Respiratory Support and Mechanisms | 2021-2025 | 107 | BE 1 | 98.54 |
| COVID-19 Clinical Research Studies | 2021-2025 | 464 | BE 3 | 97.88 |
| Hemodynamic Monitoring and Therapy | 2021-2025 | 80 | BE 3 | 96.63 |
| Cardiac Structural Anomalies and Repair | 2021-2025 | 260 | BE 6 | 96.76 |
| Traumatic Brain Injury Research | 2021-2025 | 132 | BE 7 | 95.63 |
| Intracranial Aneurysms: Treatment and Complications | 2021-2025 | 209 | BE 2 | 95.62 |
| S100 Proteins and Annexins | 2021-2025 | 66 | BE 3 | 90.46 |
| Antibiotics Pharmacokinetics and Efficacy | 2021-2025 | 321 | BE 7 | 91.03 |
| Heart Rate Variability and Autonomic Control | 2021-2025 | 783 | BE 11 | 88.28 |
| Acute Kidney Injury Research | 2021-2025 | 398 | BE 9 | 86.64 |
| Electrolyte and hormonal disorders | 2021-2025 | 186 | BE 15 | 85.37 |
| Pneumonia and Respiratory Infections | 2021-2025 | 976 | BE 20 | 86.31 |
| Blood transfusion and management | 2021-2025 | 271 | BE 2 | 81.47 |
| Optical Imaging and Spectroscopy Techniques | 2021-2025 | 566 | BE 1 | 80.59 |
| Trauma, Hemostasis, Coagulopathy, Resuscitation | 2021-2025 | 708 | BE 8 | 72.21 |
| Renal function and acid-base balance | 2021-2025 | 411 | BE 11 | 66.87 |
| Hemoglobin structure and function | 2021-2025 | 242 | BE 1 | 63.68 |
| Poisoning and overdose treatments | 2021-2025 | 740 | BE 4 | 57.29 |
| Infectious Encephalopathies and Encephalitis | 2021-2025 | 698 | BE 3 | 49.68 |
| Intraoperative Neuromonitoring and Anesthetic Effects | 2021-2025 | 715 | BE 3 | 26.71 |
